Total medical devices industry M&A deals worth $4.1bn were announced in North America in August 2021, led by Trulli Bidco’s $2.5bn acquisition of Smiths Medical, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 153.7% over the previous month of $1.62bn and a drop of 29.6% when compared with the last 12-month average of $5.84bn.
North America held a 91.95% share of the global medical devices industry M&A deal value that totalled $4.47bn in August 2021. With a 91.95% share and deals worth $4.11bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of M&A deal activity, North America recorded 20 deals during August 2021, marking a decrease of 9.09% over the previous month and a drop of 9.09% over the 12-month average. The US recorded 18 deals during the month.
North America medical devices industry M&A deals in August 2021: Top deals
The top five medical devices industry M&A deals accounted for 99.1% of the overall value during August 2021.
The combined value of the top five medical devices deals stood at $4.07bn, against the overall value of $4.1bn recorded for the month.
The top five medical devices industry M&A deals of August 2021 tracked by GlobalData were:
1) Trulli Bidco $2.5bn acquisition deal with Smiths Medical
2) The $1.1bn acquisition of Intersect ENT by Medtronic
3) Abcam $340m acquisition deal with BioVision
4) The $100m acquisition of Genuity Science by Hibercell
5) Nano-X Imaging $30m acquisition deal with USARAD Holdings